Thyme Care scores $480M valuation in new funding round

(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.)

Thyme Care’s latest …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Amy Schumer’s Cushing’s Dx; One Billion People With Obesity; Vitamin D for T1D

Comedian Amy Schumer revealed she has exogenous Cushing’s syndrome brought on by steroid injections. (CNN) The one-anastomosis gastric bypass (OAGB) procedure was not inferior to

March 6, 2024

Pentixapharm Releases Interim Report for the Third Quarter of 2024 – Biotech Investments

EQS-News: Pentixapharm Holding AG / Key word(s): Quarterly / Interim Statement Pentixapharm Releases Interim Report for the Third Quarter of 2024 12.11.2024 / 17:45 CET/CEST

November 13, 2024

Pathalys secures $105m to advance SHPT drug through approval – Pharmaceutical Technology

Pathalys has closed a $105m Series B financing round led by TCGX. Credit: PeopleImages.com – Yuri A via Shutterstock. Pathalys Pharma has secured $105m in

August 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.